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Background: Using the Directly Observed Treatment-Short course (DOTS) program the World Health Organization’s
global target was to detect 70% of new sputum-smear positive PTB cases. Smear positive PTB cases are more infectious
than the smear negative cases. The TB case detection rate remains very low in Ethiopia, but there are increases in
smear-negative PTB diagnosis which could be attributed to several factors including poor quality of sputum
smear-microscopy.
Methods: A five years retrospective record review of data between September, 2007 and August, 2012 and an in-depth
assessment of AFB staining practices of sputum smear using a standard checklist were made. The proportion of smear
positive cases relative to overall Acid Fast Bacilli (AFB) screened was determined over a five year period to indicate the
overall prevalence and the trend. Odds ratio with 95 percent confidence interval was calculated for categorical variables
using multivariate Logistic Regression model to assess the strength of association.
Result: A total of 1266 individuals’ data were reviewed. The majority of the study participants were male, 704
(55.6%), and rural residents, 690 (54.5%). The overall prevalence rate of smear positive PTB was 21.6%. Age
categories between 15–24 and 25–34 years were independent predictors of smear positive PTB with adjusted
odds ratio of 2.246 [95% CI (1.098-4.597)] and 2.267 [95% CI (1.107-4.642)], respectively. More males were affected
by PTB than females with an adjusted odds ratio of 1.426 [95% CI (1.083-1.879)]. An in-depth interview with the
respective laboratory chiefs showed that quality control measures for sputum smear microscopy were used at
different levels of the testing activities; however, equipment function verification as a quality control measure was
not accomplished regularly in all of the study hospital laboratories.
Conclusion: The smear positive PTB case detection rate indicated in this study is significantly lower than the
countries which met the 70% target of the World Health Organization. Lack of feedback mechanisms in the
External Quality Assurance schemes of sputum smear microscopy render the opportunity for improvement
difficult; Serial sputum examination showed a considerable rate of positivity in the second sputum sample when
compared with the others.
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The TB epidemic is in a steady, although modest and slow,
decline. Nonetheless, more than nine million people still
develop active TB each year and nearly two million die [1].
The Directly Observed Treatment-Short course (DOTS)
strategy of tuberculosis is the World Health Organizations
(WHO) recommended approach, which involves passive
detection of PTB cases, primarily using sputum smear mi-
croscopy. The global target using the DOTS program was
to detect 70% of new sputum-smear positive PTB cases
[2]. However, only 32% of the new smear positive PTB
cases estimated were detected throughout the globe [3].
Ethiopia ranked seventh among the world 22 highest
burden countries, with a smear-positive TB case notifica-
tion rate of 57 per 100,000 populations [4] and 54 deaths
per 100,000 populations [5]. In 2010, it was reported that
DOTS coverage reached 100% and TB treatment was inte-
grated into general health services in Ethiopia. However,
TB case detection rate remains very low in Ethiopia (36%)
[4]. The increases in smear-negative PTB diagnosis in
Ethiopia could be attributed to several factors: poor quality
of sputum smear-microscopy, non adherence to diagnostic
algorithm, and HIV-TB co-infection [6,7]. The magnitude
of smear positive PTB in the eastern part of Ethiopia is
not well studied.
Microscopy remains the mainstay of rapid TB case de-
tection, especially for those patients who are most infec-
tious to others, where the bacterial load involved often
reflects the extent of the disease and the need for immedi-
ate treatment. The sensitivity of the direct Ziehl-Neelsen
(ZN) smear depends on the diligence of the technician
and on the use of appropriate technique [7,8].
External Quality Assurance (EQA) programs are needed
to ensure that smears are performed and interpreted cor-
rectly and that all microscopy centres achieve an accept-
able level of performance. Effective EQA programs are,
however, labour-intensive and complex, requiring dedi-
cated staffs for onsite supervisory visits and to recheck re-
sults for relatively large numbers of smears [9,10]. In
addition to that, quality of AFB sputum smears micros-
copy just like other laboratory tests in hospital laboratories
from the eastern part of Ethiopia would be compromised.
This is mainly due to being a resource poor setting [11].
Direct microscopy of sputum-smear using the Ziehl-
Neelsen technique is the only means to diagnose PTB in
Ethiopia [12]. Assessing the AFB laboratory staining prac-
tices on the prevalence of smear positive PTB was found
to be very crucial. In Ethiopia, this inquiry has not been
adequately addressed, and no studies have previously been
conducted in the eastern part of the country. Therefore,
this study was designed to assess the magnitude of smear
positive PTB. Further the study looked at AFB Staining
practice of sputum smear in the hospital laboratories. Un-
derstanding the prevalence of smear positive PTB in theeastern part of the country could provide data relevant for
TB programmers, researchers, decision makers and stake-
holders striving to the prevention and control of TB.
Methods
Study setting and period
The study was conducted amongst hospitals in Eastern
Ethiopia. It includes Dire Dawa, DilChora hospital; Harar,
HiwotFana hospital and Jijiga, Karamara hospital. Dire
Dawa administration is a city located 500 km away from
the capital Addis Ababa. Harar is a town located 510 km
away from Addis Ababa and is the capital of the Harari re-
gional state. Jijiga is a town located about 615 km away
from Addis Ababa, which is the capital of the Somali re-
gion. The hospitals were initially conveniently selected for
this study for budgetary reason. The hospitals were also
assumed to represent two regional states and an adminis-
tration in the eastern part of Ethiopia. HiwotFana hospital
was one of the two public hospitals in Harar town,and in-
cluded by lottery method; whereasKaramara and DilChora
hospitals were the only public hospitals in Jijiga and Dire
Dawa, respectively. The three hospitals were estimated to
serving for 1–1.5 million people each. Data was collected
from September to October, 2012 (Figure 1).
Study design
From September, 2007 to August, 2012, a cross-sectional
retrospective study based on record review, was conducted
to determine the trend and prevalence of smear positive
PTB. This was supplemented qualitatively by in-depth
interview with the respective hospital laboratory chiefs.
The interview explored the laboratories overall practices
of AFB examination in the last five years.
Study population and samples
In the three hospitals in the last five years there were 8862
patients screened for the AFB. The study population in-
cludes individuals screened for AFB in the study hospitals.
In order to determine the prevalence the following sample
size calculation was used. The population proportion
taken was 50% as there was no previous study in the set-
ting, marginal error considered was 4% with a design ef-
fect of 2, and the confidence level used was 95% [13]. And
with the added 10% non response rate the final sample
size was 1320. The sample size obtained during the study
was 1266, and every 7th of the total 8862 patients were in-
cluded to reach this sample size. Four hundred twenty-
two individuals were selected from each of the three
hospitals.
Therefore, a total of 1266 individuals with a complete
data register including age, sex, residence and results of
serial sputum smear examinations were included. How-
ever, those with incomplete information for any of the
above variables were excluded from study.
Figure 1 Map indicating study areas: Harar, Dire Dawa, and Jijiga, Eastern Ethiopia. Source: http://www.goodtogrowinc.org/where-we-work.html.
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tory Assessment tool were conducted with chiefs of the
respective hospital laboratories to qualitatively supplement
the secondary data. The informant chiefs were serving in
the hospital laboratories for more than five years during
the data collection period and were recognized as
knowledgeable on each and every activity of the respective
laboratories.
Data collection and quality control
For the secondary data a standard questionnaire was used
for recording information extracted from the TB registry.
Data about gender, age, residence and serial sputum exam-
ination results of patients were obtained from the registry.
Supplementary qualitative information about AFB staining
practices were explored by in-depth interview using
WHO’s Tuberculosis Laboratory Assessment tool (3rd
draft, 2002) with chiefs of the respective hospital labs.
Smear positive PTB cases were defined as those individ-
uals with two or more sputum smears positive for AFB
examination. Data was collected by three trained labora-
tory technologists who were working at Haramaya Univer-
sity under intensive supervision of the researcher. The
data collectors had two days training which focused on
how to collect complete data from AFB record books and
how to conduct in-depth interviews with the hospital la-
boratory chiefs using the standard checklist provided. All
completed data collection forms were examined for clarity
and consistency by the principal investigator of the study.
Data analysis
The data were entered into SPSS version-16, and Chi-
square and P value computation was accomplished to de-
pict the possible association that might exist between the
dependent and independent variables. Odds ratio with 95
percent confidence interval was calculated for categoricalvariables using multivariate Logistic Regression model to
assess the strength of association. The dependent variable
of this study was the magnitude of smear positive PTB,
whereas the independent variables were socio-demographic
characteristic of the study participants and the study health
service institutions.Ethical consideration
The study was ethically approved by Haramaya University
Institutional Research and Ethical Review Committee, and
the data collection was carried out after submitting the
ethical clearance letter to the respective hospital adminis-
trations and chiefs of laboratories, and informed consent
were given by chiefs of the hospital laboratories.Results
Characteristics of study participants
A total of 1266 individuals, with a response rate of
95.9%, 422 from each hospital (HiwotFana, DilChora,
and Karamara), were studied. The majority of the study
participants were male, 704 (55.6%), and rural resi-
dents, 690 (54.5%). The median age of the study popula-
tion was 30 years with a standard deviation of 14.9 years
(Table 1).
The chiefs of the three study hospital laboratories inter-
viewed were male between the age of 33 and 37; who had
been serving in the respective laboratories for more than
five years.
The data obtained from the three study hospital labora-
tories showed notable similarities in both contents and
record keeping practice. Despite some incompleteness of
information in the AFB records, the differences in record
keeping between the study hospital laboratories were not
significant.
Table 1 Characteristic of study participants by study hospitals in three governmental hospitals, Eastern Ethiopia,
2007-2012
Characteristic Karamara hospital no. (%) DilChora hospital no. (%) HiwotFana hospital no. (%) Total
Gender
Female 180 (42.7) 178 (42.2) 204 (48.3) 562 (44.4)
Male 242 (57.3) 244 (57.8) 218 (51.7) 704 (55.6)
Total 422 (33.3) 422 (33.3) 422 (33.3) 1266 (100)
Age group (in years)
<15 35 (8.3) 4 (0.9) 36 (8.5) 75 (5.9)
15-24 130 (30.8) 118 (28) 116 (27.5) 364 (28.8)
25-34 100 (23.7) 124 (30.1) 134 (31.8) 358 (28.3)
35-44 65 (15.4) 66 (15.6) 73 (17.3) 204 (16.1)
45-55 51 (12.1) 63 (14.9) 35 (8.3) 149 (11.8)
>55 41 (9.7) 47 (11.1) 28 (6.6) 116 (9.2)
Total 422 (33.3) 422 (33.3) 422 (33.3) 1266 (100)
Residence
Rural 253 (60) 229 (54.3) 208 (49.3) 690 (54.5)
Urban 169 (40) 193 (45.7) 214 (50.7) 576 (45.5)
Total 422 (33.3) 422 (33.3) 422 (33.3) 1266 (100)
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The overall prevalence rate of smear positive PTB was
21.6%. Almost 25% of the males and 19% of the females
studied were positive for sputum smear microscopy.
Smear positive PTB was significantly higher in rural than
urban residents [AOR: 1.573, 95% CI (1.193-2.076)]
(Table 2).
Age categories between 15–24 and 25–34 years were
independent predictors of smear positive PTB with ad-
justed odds ratio of 2.246 [95% CI (1.098-4.597)] and
2.267 [95% CI (1.107-4.642)], respectively. More males
were affected by PTB than females with an adjusted
odds ratio of 1.426 [95% CI (1.083-1.879)] (Table 2).
Smear positive pulmonary TB was highly prevalent at
HiwotFana hospital followed by Karamara and DilChora
hospitals with a prevalence of 27%, 21.1%, and 18.9%, re-
spectively. At the same time, it was significantly higher at
HiwotFana hospital [AOR: 1.449, 95% CI (1.047-2.006)]
(Table 2).
The trend of smear positive PTB does not show any
considerable change during the five years of examin-
ation. The prevalence of smear positive PTB was higher
in males than their female counterparts and also in rural
than their urban counterparts (Figure 2).
Out of the 1266 study participants, 244 (19.3%), 33
(2.6%) and 13 (1.0%) were with three positive smears, two
positive smears and one positive smear, respectively. How-
ever, the remaining 976 (77.1%) were negative for AFB
examination (Table 3).
No statistically significant variability was observed be-
tween the first spot samples, second morning samplesand the third spot samples by year of examinations. In
this study, the rate of positivity was increased from
21.6% in the first spot sample to 22.4% in the second
morning sample. However, no increment was observed
from the third spot sample, rather there was a reduction
in the positivity rate to 20.9% (Table 4).
Serial sputum examinations do not show any signifi-
cant variability between the first spot samples, second
morning sputum samples and the third spot samples by
year of examinations. On average 4.5 suspected cases
had to be screened to diagnose one smear positive case.
A total of 283 (22.4%) individuals with suspected PTB
had at least one positive smear. Of these, 273 (21.6%)
were positive from the first specimen; the other 10
(0.8%) were positive on the second morning specimen
but not the first. However, eight and eighteen specimens
were negative from the first spot specimen and the sec-
ond morning specimen to the third specimen, respect-
ively (Table 4).AFB examination practices according to the standard
checklist of WHO’s TB lab assessment tool
An in-depth interview with the chief of each hospital la-
boratory was conducted using a standard checklist of
WHO’s Tuberculosis Laboratory Assessment tool (3rd
draft, 2002). The interview assessed the laboratories
overall practices in the five year period. The assessment
showed considerable similarity between the study hos-
pital laboratories practice, with the exception of some
minor inconsistencies (Table 5).
Table 2 Socio demographic characteristic of the study participants and its association with smear positive pulmonary
TB in three governmental hospitals, Eastern Ethiopia, 2007-2012
Characteristic Total examined no. (%) Smear positive no. (%)¥ COR (95% CI) AOR (95% CI)
Gender
Female 562 (44.4) 108 (19.2) 1 1
Male 704 (55.6) 175 (24.9) 1.391 (1.061-1.823)* 1.426 (1.083-1.879)*
Age group (in years)
<15 75 (5.9) 10 (13.3) 1 1
15-24 364 (28.7) 92 (25.3) 2.199 (1.085-4.456)* 2.246 (1.098-4.597)*
25-34 358 (28.3) 93 (26.0) 2.281 (1.126-4.623)* 2.267 (1.107-4.642)*
35-44 204 (16.1) 46 (22.5) 1.892 (0.901-3.976) 1.858 (0.875-3.943)
45-55 149 (11.8) 24 (16.1) 1.248 (0.563-2.767) 1.280 (0.569-2.878)
>55 116 (9.2) 18 (15.5) 1.194 (0.518-2.749) 1.201 (0.514-2.804)
Residence
Rural 690 (54.5) 177 (25.7) 1.530 (1.166-2.007)** 1.573 (1.193-2.076)**
Urban 576 (45.5) 106 (18.4) 1 1
Study hospital
Karamara 422 (33.33) 89 (21.1) 1 1
DilChora 422 (33.33) 80 (18.9) 0.875 (0.624-1.227) 0.871 (0.617-1.228)
HiwotFana 422 (33.33) 114 (27) 1.385 (1.008-1.903)* 1.449 (1.047-2.006)*
COR: Crude Odds Ratio; AOR: Adjusted Odds Ratio; CI: Confidence Interval.
*P < 0.05; **: p < 0.01.
¥the percentage is calculated from the total examined in the respective characteristic.
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and qualification of lab staffs to perform sputum smear
microscopy. However, to the best of their knowledge, the
chiefs indicated the absence of a national TB manual and
guideline or protocol of quality assurance of smear mi-
croscopy, either in the respective hospital laboratories or
in the country.
Quality control measures for sputum smear microscopy
were used at different levels of the testing activities; quality
control during specimen reception/handling by using
clearly described specimen rejection criteria were used in
















Figure 2 Five years trend of smear positive PTB by gender, residenceduring stain preparation and in the staining procedure
along with quality control measures on reading and
reporting of results was performed with some irregularity
in the study hospitals. However, equipment function verifi-
cation as a quality control measure was not accomplished
regularly in all of the study hospital labs.
All the study hospital laboratories regularly apply in-
ternal quality assurance schemes for sputum smear mi-
croscopy at the beginning of every month. Even though
there are no regular feedback mechanisms to detect areas
that need improvement and no means to ensure the im-











and study hospital, Eastern Ethiopia, 2007–2012.
Table 3 Serial sputum sample results by year of examination, Eastern Ethiopia
Serial sputum sample results Year of examination Total
2007/08 no. (%) 2008/09 no. (%) 2009/10 no. (%) 2010/11 no. (%) 2011/12 no. (%)
Three positive smears 53 (21.0) 48 (18.8) 52 (20.6) 49 (19.2) 42 (16.7) 244 (19.3)
Two positive smears 2 (0.8) 9 (3.5) 7 (2.7) 10 (3.9) 5 (2.0) 33 (2.6)
One positive smear 1 (0.4) 3 (1.2) 2 (0.8) 0 (0) 7 (2.8) 13 (1.0)
Negative smears 196 (77.8) 195 (76.5) 191 (75.6) 196 (76.9) 198 (78.6) 976 (77.1)
Total 252 (19.9) 255 (20.1) 252 (19.9) 255 (20.1) 252 (19.9) 1266 (100)
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assurance program organized by the respective regional la-
boratories using slide rechecking methods.
The work load of the lab staffs on sputum smear mi-
croscopy was about 7 to 9 smears examined per worker
per day. The lab staffs implementation of safety practice in
sputum smear microscopy appeared to be of good quality.
They used appropriate disinfectants regularly and dis-
posed of waste based on biosafety requirements. However,
availability of training on safe lab practices was scarce, and
there were no regular health check-ups of laboratory
workers in any of the study hospitals using chest x-ray,
sputum examination or any other mechanisms.
The role of in-service training to enhance quality
laboratory service is highly significant. Some of the la-
boratory workers at Karamara hospital did not receive in-
service training on sputum smear microscopy, whereas
those in DilChora and HiwotFana hospitals attended train-
ing organized by Haramaya University in collaboration
with Ethiopian Health and Nutrition Research Institute
(EHNRI) and Centers for Disease Control and Prevention-
Ethiopia (CDC-E) at different training periods.
The procurement system for lab supplies including re-
agents, consumables and equipment functioned efficiently




2007/08 no. (%) 2008/09 no. (%) 2009/10 no.
First spot sample
Positive 56 (22.2) 55 (21.6) 56 (22.2)
Negative 196 (77.8) 200 (78.4) 196 (77.8)
Total 252 (19.9) 255 (20.1) 252 (19.9)
Second morning sputum sample
Positive 57 (22.6) 58 (22.7) 60 (23.8)
Negative 195 (77.4) 197 (77.3) 192 (76.2)
Total 252 (19.9) 255 (20.1) 252 (19.9)
Third spot sample
Positive 55 (21.8) 53 (20.8) 56 (22.2)
Negative 197 (78.2) 202 (79.2) 196 (77.8)
Total 252 (19.9) 255 (20.1) 252 (19.9)supplies required in clinical laboratory services. This was
indicated by the very rare interruption of the test due to
shortage of supplies. However, the maintenance system for
equipment in all the study hospitals was highly deficient
resulting in microscopes and other equipment being de-
posited in storage rooms when they may only have re-
quired minor repairs.
Discussion
Smear positive PTB was highly prevalent between the ages
of 15–34 years, and more males were affected than fe-
males. Unlike other studies which have shown a higher
prevalence of PTB in the elderly (>45 years) [14], this
study revealed that the risk to get smear positive pulmon-
ary TB was about a 2.3 times higher among people in the
age group of 15–34 years than the other age categories.
This might be explained by the more interactive nature of
the people in this age category when compared with those
under 15 years and the elderly. This could also be related
to the higher association of PTB with HIV/AIDS [15]. The
higher proportion of a smear-positive sputum sample in
males than females is consistent with data from Ethiopia
[2] and other countries also [16,17], and could reflect oc-
cupational, behavioral or immunological factors that con-
tribute to risk.y year of examination, Eastern Ethiopia
ation Total P-value
(%) 2010/11 no. (%) 2011/12 no. (%)
P = 0.98
55 (21.6) 51 (20.2) 273 (21.6)
200 (78.4) 201 (79.8) 993 (78.4)
255 (20.1) 252 (19.9) 1266 (100)
P = 0.91
58 (22.7) 50 (19.8) 283 (22.4)
197 (77.3) 202 (80.2) 983 (77.6)
255 (20.1) 252 (19.9) 1266 (100)
P = 0.89
54 (21.2) 47 (18.7) 265 (20.9)
201 (78.8) 205 (81.3) 1001 (79.1)
255 (20.1) 252 (19.9) 1266 (100)
Table 5 AFB examination practices according to the






Presence of national TB lab manual 0 (0) 3 (100)
Presence of national guideline (or protocol)
of Quality Assurance
0 (0) 3 (100)
Quality control measures during
Specimen reception/handling 2 (66.7) 1 (33.3)
Stains preparation 3 (100) 0 (0)
Staining 1 (33.3) 2 (66.7)
Equipment function 1 (33.3) 2 (66.7)
Reading and reporting 3 (100) 0 (0)
Presence of Internal quality
assessment program (IQA)
3 (100) 0 (0)
Participation in External Quality
Assessment program (EQA)
3 (100) 0 (0)
Presence of feedback mechanism
on results of EQA
0 (0) 3 (100)
Trainings on safe lab practices (safety) 2 (66.7) 1 (33.3)
Regular health check-up of lab workers 0 (0) 3 (100)
Availability of in-service trainings
on sputum smear microscopy
2 (66.7) 1 (33.3)
Frequent interruption of lab work
due to shortage of supplies for
sputum smear microscopy
1 (33.3) 2 (66.7)
Presence and adequacy of maintenance
system for equipments
0 (0) 3 (66.7)
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smear –positive PTB than that of their urban counter-
parts. This could be due to lack of awareness and poor
housing conditions among the rural inhabitants than the
urban dwellers. A study from Tigray showed that rural resi-
dents were less knowledgeable about PTB than their urban
counterparts [18]. Furthermore, differences in literacy rate
and access to health services could account for the variation
in TB-knowledge among urban and rural respondents [19],
and for the variation in the prevalence of PTB.
This study revealed the overall prevalence of smear posi-
tive PTB during the five year period to be 21.6%, which in-
dicates that the disease is of major clinical significance in
the study areas. This finding is higher than studies from
south west Ethiopia which showed a prevalence of 10.9%
from Agaro [20] and 8.5% from Jimma University special-
ized hospital [21]. This difference could be due to variability
in the awareness of communities for early diagnosis and
treatment or the increased susceptibility to pulmonary TB
due to excessive exposure to predisposing factors like
smoking and khat chewing habits in the study areas of the
east when compared to south western part of the nation[22]. Ethiopia is among the countries with a high burden
of TB. Despite the implementation of control strategies
against PTB in the 1960’s the impact in curbing the mag-
nitude of the problem has been insignificant [23]. This
finding again emphasizes the call for devising effective
preventive and control strategies against PTB both in the
eastern Ethiopia and other parts of the country.
The increase in the prevalence of smear positive TB in
the study area could also be explained by the effective active
follow up of the nongovernmental organizations (NGOs)
like International Center for AIDS care and treatment
Program- Ethiopia (ICAP-E) who focused mainly on TB-
laboratory activities in the Eastern part of Ethiopia, that
could enhance the quality of AFB testing procedure and
hence the rate of positivity. A study from Tigray showed a
comparable prevalence of smear-positive PTB to be 24.6%
[6], and an increased proportion of smear positive cases
were also reported from southern region of Ethiopia [24].
The principal WHO measure of case detection is an in-
crement for new smear-positive cases in DOTS program
[25]. However, this finding from eastern Ethiopia is very
low when compared with the case detection rate achieved
in Africa (46%), and the 77 countries which met the 70%
target by the end of 2006. According to this WHO report,
Ethiopia is accounting for more than one-quarter of “miss-
ing” cases [25]. This decreased smear positive case detec-
tion rate in the study area and in the country may show a
lack of emphasis on sputum smear microscopy or an in-
complete geographical coverage of DOTS.
The decreases in the magnitude of smear positive PTB
as compared with other areas could also be explained by
the cumulative effects of contributing factors including:
lack of regular in-service trainings on sputum smear mi-
croscopy; absence of quality assurance guidelines or proto-
cols of smear microscopy; and nonexistence of equipment
function verification scheme as quality control measure in
the study hospitals among others.
Smear positive pulmonary TB showed a statistically sig-
nificant variability between the study hospitals. It was
highly prevalent at HiwotFana followed by Karamara and
DilChora hospitals, respectively. This difference could be
attributed to; variations in geographical coverage of DOTS
strategy in the communities; differences in the respective
hospital administrations; differences in commitment of la-
boratory staffs and opportunities for training that enhances
quality services in carrying out all pre analytical, analytical
and post analytical procedures for sputum smear micros-
copy. In addition, differences in frequency of monitoring
and support from regional laboratories and NGO’s like
ICAP-E could contribute to this variability.
The study does have limitations. The retrospective study
design limited our ability to gather data about factors that
may influence quality of sputum smear microscopy from
the patients’ side, for instance, quality of sputum specimens
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have been investigated. In addition, even though a detailed
interview was conducted with the respective hospital
laboratory chiefs to assess important factors associated with
quality of sputum smear microscopy, it was difficult to
judge the actual pre-analytical, analytical and post-analytical
sputum smear microscopy procedures employed in the
laboratories in the past five years.
Conclusion
The overall prevalence of sputum smear positive cases
of 21.6% indicates that the disease is of major clinical
significance in the study areas. However, the case
detection rate pointed out in this study is significantly
lower than the target set by WHO; this signifies the
need to improve the rigor of the sputum smear micros-
copy test. The most vulnerable groups were males,
rural residents and individuals in the age range 15–34
years. Designing and implementing preventive mea-
sures targeting these gender; residence and age cate-
gories is recommended. An opportunity to improve the
situation has been missed due to the lack of feedback
mechanisms in the external quality assurance program.
Serial sputum examination showed a considerable rate of
positivity in the second morning sputum sample when
compared with the others. However, the third spot sputum
sample showed no positivity increase in comparison to
the first spot and the second morning sputum samples.
Further studies are also recommended.
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